BriaCell Therapeutics
BCTX | NASDAQ
$3.30
-$0.09 (-2.65%)
At close: Nov 16, 2026, 4:00 PM ET
$3.30
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
BriaCell Therapeutics Company Profile
Company profile explainedCompany Profile
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation. This crucial study evaluates its effectiveness when utilized in conjunction with immune checkpoint inhibitors for treating breast cancer. Beyond its flagship program, BriaCell has forged a collaborative research and development partnership with the National Cancer Institute (NCI). This alliance is dedicated to progressing Bria-OTS, a personalized immunotherapy designed for advanced breast cancer patients, and BriaDx, a proprietary diagnostic assay. The company's main offices are situated in West Vancouver, Canada.
Key Executives
| Name | Position |
|---|---|
| William V. Williams | Chief Executive Officer, President & Director |
| Gadi Levin | Chief Financial Officer & Corporate Secretary |
| Charles Louis Wiseman FACP | Founder, Principal Research Advisor & Member of Scientific Advisory Board |
| Giuseppe Del Priore | Chief Medical Officer |
| Miguel A. Lopez-Lago | Chief Scientific Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 28, 2026 | 10-K | Annual Report |
| Jun 26, 2026 | 8-K | Current Report |
| Jun 09, 2026 | 10-Q | Quarterly Report |
| Jun 03, 2026 | 8-K | Current Report |
| Jun 02, 2026 | 424B5 | Filing |
| Mar 31, 2026 | 8-K | Current Report |
| Mar 10, 2026 | 10-Q | Quarterly Report |
| Mar 09, 2026 | 8-K | Current Report |
| Feb 26, 2026 | 25-NSE | Filing |
| Feb 20, 2026 | 8-K | Current Report |
BriaCell Therapeutics
| Country | Canada |
| IPO Date | Mar 14, 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 16 |
| CEO | William V. Williams |
Contact Details
Bellevue Centre West Vancouver,
BC V7T 2X1 Canada
Stock Details
| Ticker Symbol | BCTX |
| Exchange | NASDAQ |
| Fiscal Year | August - July |
| Reporting Currency | USD |
| CIK Code | 0001610820 |
| CUSIP Number | 107930307 |
| ISIN Number | CA1079303071 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove BCTX